Alphabet CFO Anat Ashkenazi jumps from GLP-1 boom to generative AI
Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli Lilly Eli Lilly “Hundreds of thousands of people fill scripts for Mounjaro and Zepbound, yet we understand the frustration from those facing prescription delays or uncertainties getting their medicine,” Ashkenazi said on Eli Lilly’s first-quarter earnings call in April. The two drugs are part of a …